Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR - Wikidata - wikimedia - TriplyDB

Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR

Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR

http://www.wikidata.org/entity/Q35537136

about

Advancing the understanding of autism disease mechanisms through genetics mTOR and MAPK: from localized translation control to epilepsy A Subset of Autism-Associated Genes Regulate the Structural Stability of Neurons.Autism As a Disorder of High Intelligence Cyfip1 Regulates Presynaptic Activity during Development New insights into the regulatory function of CYFIP1 in the context of WAVE- and FMRP-containing complexes.Bio-collections in autism research.A Common CYFIP1 Variant at the 15q11.2 Disease Locus Is Associated with Structural Variation at the Language-Related Left Supramarginal Gyrus.A Genome-Wide Association Study of Attention Function in a Population-Based Sample of Children.Reduced CYFIP1 in Human Neural Progenitors Results in Dysregulation of Schizophrenia and Epilepsy Gene Networks.Collybistin binds and inhibits mTORC1 signaling: a potential novel mechanism contributing to intellectual disability and autism.Increased abundance of translation machinery in stem cell-derived neural progenitor cells from four schizophrenia patients.Dysfunctional mTORC1 Signaling: A Convergent Mechanism between Syndromic and Nonsyndromic Forms of Autism Spectrum Disorder?Lessons learned from studying syndromic autism spectrum disorders.Recurrent 15q11.2 BP1-BP2 microdeletions and microduplications in the etiology of neurodevelopmental disorders.The non-coding RNA BC1 regulates experience-dependent structural plasticity and learning.Genetic and morphological features of human iPSC-derived neurons with chromosome 15q11.2 (BP1-BP2) deletions Modeling the neuropsychiatric manifestations of Lowe syndrome using induced pluripotent stem cells: defective F-actin polymerization and WAVE-1 expression in neuronal cells Association study and mutation sequencing of genes on chromosome 15q11-q13 identified GABRG3 as a susceptibility gene for autism in Chinese Han population Genomics in neurodevelopmental disorders: an avenue to personalized medicine

P2860

Q28069757-AB461968-A1B9-4198-B7D0-CFEC8EA3619E Q28076827-27C69865-B230-4B3C-A362-5BD3D2F0C24C Q28079929-2A514B34-3B55-4DF4-9BD8-BE4834E2E810 Q28277283-11CA69EA-F35E-425F-B22F-1C845AAC4960 Q28566588-67A2C72C-E020-4CB6-8FCE-80160A7032F1 Q33588069-F36F5A9F-E1E4-484E-A0E3-81637E66EA54 Q33892169-2CD0CF03-852E-40B3-907F-70D1C33F93BE Q36062997-954B33E4-E1AE-4A37-BFCE-5DE986E0722E Q36140499-77BFC700-314B-418B-B1DC-C2E4041088AC Q36519585-F7E253CD-23AE-41AD-8311-D5053D705699 Q36695840-9654AC9F-14C6-48CB-BAEE-E4E3B0684EBE Q37058606-F7EB2953-0049-442E-A8F7-873E45841F11 Q37729341-F649BAB4-8430-4D06-897A-F0473079C68F Q38992291-1436073D-741E-42BE-96C0-235B3C69FB23 Q39448846-547118E9-CA90-4014-9509-0B14C72FCC11 Q41446846-A5C64634-1046-4B2F-9B18-A5093A82E371 Q42605473-AC1B446B-C520-480A-879C-F62A052BA823 Q57193586-923242DF-B41A-43A1-91B7-1B29FE7D3A18 Q58782917-36F67D4A-9235-43C2-A274-BBDD4A5602A0 Q58797492-39A88BD7-152A-48BC-9AE9-D5195A4CFCB5

P2860

Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR

http://www.wikidata.org/entity/Q35537136

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR

@ast

Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR

@en

type

label

Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR

@ast

Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR

@en

prefLabel

Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR

@ast

Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR

@en

P1433

Q35537136-78E325F5-5A8B-4AF8-A7D7-A95701FD63C4

P1476

Q35537136-AD48B53C-6FB9-43DB-BEAF-1B5DB905D7CF

P2093

Q35537136-08A7E9C2-2134-4F29-A53F-AB82AABBF5AD

Q35537136-354B0C85-D2FD-4B9C-AA65-13697148A195

Q35537136-4F16B9DF-E4DA-46CE-AA03-26EE4D0EA84A

Q35537136-556C323B-DE41-47B3-9762-FABEE0FBE38E

Q35537136-C77FA0DB-F259-4B2C-B11E-CF115FD37C24

Q35537136-D96EF676-00F0-4BEA-A9DE-ACD40FA2963F

Q35537136-EEA6F5B1-CBC8-4F9A-AE73-EA5B84A5D5F3

Q35537136-FED567E3-2100-4044-9469-2F0FE89D9638

P2860

Q35537136-0225841A-532E-470D-8343-5D91564DBD65

Q35537136-033CB6AD-390D-4479-BD71-F74DDE1F9643

Q35537136-07BA41B2-3D3A-4886-A8DA-E41FAC90698E

Q35537136-09635C6A-407B-42B6-86B4-F7C472D7772B

Q35537136-09906526-63DF-4CBB-A817-23D3828B3EC5

Q35537136-0D6C549A-3714-47E8-96AB-2C99AC6A01D7

Q35537136-10BEDC2B-EA9C-4537-8283-48D12945C63C

Q35537136-11994B16-2B6E-48D8-A4CD-AED1F3E76A04

Q35537136-1508A04B-48E5-48E9-8EEB-BC9978E63D5D

Q35537136-17799C2E-9D75-4BFE-9827-49E8D9B930B0

P2888

Q35537136-5166B0AA-A960-4F55-80CD-5258E59BF953

P304

Q35537136-C653A149-9A62-46D6-9B4C-8A67C87B7148

P31

Q35537136-11DD9DC2-8936-4DD8-B19A-3F73BD6B8E7A

P356

Q35537136-E8BF358E-24B9-4FAF-A1A0-727CCD52FD8B

P407

Q35537136-51DAF448-F13E-4285-A77E-15D13CF63AA7

P433

Q35537136-59EAA808-371E-456B-ABA0-9F9D710BAD90

P478

Q35537136-F6A58B2D-B9FD-442D-BE80-AA6E246C2700

P50

Q35537136-24B779C4-D8DA-4A80-B5C3-3D9CAD851B4F

Q35537136-70ED5DF8-8829-4203-A51E-B9E212445BC8

Q35537136-F8EADD5F-0DFD-4441-9D21-0DFF1765375E

P577

Q35537136-6A247043-273F-4B55-8A73-FBA25A292ADA

P5875

Q35537136-6D39A96F-276B-40ED-B2F4-D078F6884DE1

P698

Q35537136-AC206944-2322-4C45-95DE-0590AAF76AFA

P932

Q35537136-2B0A86BF-04A7-43F4-82FA-AA41FA5CD030

P356

P1433

Molecular Psychiatry

P1476

Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR

@en

P2093

B R Bill

http://www.w3.org/2001/XMLSchema#string

B S Abrahams

http://www.w3.org/2001/XMLSchema#string

D H Geschwind

http://www.w3.org/2001/XMLSchema#string

E Herman

http://www.w3.org/2001/XMLSchema#string

F Gao

http://www.w3.org/2001/XMLSchema#string

G Coppola

http://www.w3.org/2001/XMLSchema#string

J M Berg

http://www.w3.org/2001/XMLSchema#string

Y Nishimura

http://www.w3.org/2001/XMLSchema#string

P2860

A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P

Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways

The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP

The autism genetic resource exchange: a resource for the study of autism and related neuropsychiatric conditions

Functional impact of global rare copy number variation in autism spectrum disorders

Common genetic variants on 5p14.1 associate with autism spectrum disorders

Autism genome-wide copy number variation reveals ubiquitin and neuronal genes

FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism

Large recurrent microdeletions associated with schizophrenia

Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits

P2888

P304

1069-1078

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MP.2014.124

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Clark Rosensweig

Asami Oguro-Ando

P577

2014-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266947990

http://www.w3.org/2001/XMLSchema#string

P698

25311365

http://www.w3.org/2001/XMLSchema#string

P932

4409498

http://www.w3.org/2001/XMLSchema#string